PortfoliosLab logoPortfoliosLab logo
TRT vs. AMPH
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TRT vs. AMPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Trio-Tech International (TRT) and Amphastar Pharmaceuticals, Inc. (AMPH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TRT achieves a 80.21% return, which is significantly higher than AMPH's -32.34% return. Over the past 10 years, TRT has outperformed AMPH with an annualized return of 19.81%, while AMPH has yielded a comparatively lower 1.39% annualized return.


TRT

1D
-4.02%
1M
2.23%
YTD
80.21%
6M
183.04%
1Y
391.96%
3Y*
70.43%
5Y*
31.36%
10Y*
19.81%

AMPH

1D
-1.79%
1M
-20.32%
YTD
-32.34%
6M
-34.30%
1Y
-30.33%
3Y*
-27.06%
5Y*
-0.72%
10Y*
1.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TRT vs. AMPH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
TRT
Trio-Tech International
80.21%127.88%14.60%12.66%-66.49%239.01%-0.71%62.20%-64.91%111.35%
AMPH
Amphastar Pharmaceuticals, Inc.
-32.34%-27.88%-39.97%120.74%20.31%15.81%4.25%-3.07%3.43%4.45%

Correlation

The correlation between TRT and AMPH is -0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.05

Correlation (10Y)
Calculated over the trailing 10-year period

0.06

Correlation (All Time)
Calculated using the full available price history since Jun 26, 2014

0.07

Fundamentals

Market Cap

TRT:

$116.29M

AMPH:

$841.82M

EPS

TRT:

$0.07

AMPH:

$1.67

PE Ratio

TRT:

167.51

AMPH:

10.83

PEG Ratio

TRT:

18.48

AMPH:

0.57

PS Ratio

TRT:

2.56

AMPH:

1.19

PB Ratio

TRT:

3.39

AMPH:

1.09

Total Revenue (TTM)

TRT:

$41.83M

AMPH:

$720.53M

Gross Profit (TTM)

TRT:

$10.27M

AMPH:

$341.13M

EBITDA (TTM)

TRT:

$2.03M

AMPH:

$155.96M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TRT vs. AMPH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TRT
TRT Risk / Return Rank: 9595
Overall Rank
TRT Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
TRT Sortino Ratio Rank: 9494
Sortino Ratio Rank
TRT Omega Ratio Rank: 9393
Omega Ratio Rank
TRT Calmar Ratio Rank: 9797
Calmar Ratio Rank
TRT Martin Ratio Rank: 9797
Martin Ratio Rank

AMPH
AMPH Risk / Return Rank: 1515
Overall Rank
AMPH Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
AMPH Sortino Ratio Rank: 1919
Sortino Ratio Rank
AMPH Omega Ratio Rank: 1818
Omega Ratio Rank
AMPH Calmar Ratio Rank: 1616
Calmar Ratio Rank
AMPH Martin Ratio Rank: 88
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TRT vs. AMPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Trio-Tech International (TRT) and Amphastar Pharmaceuticals, Inc. (AMPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


TRTAMPHDifference
Sharpe ratioReturn per unit of total volatility

+3.77

Sortino ratioReturn per unit of downside risk

+4.38

Omega ratioGain probability vs. loss probability

1.52

0.92

+0.60

Calmar ratioReturn relative to maximum drawdown

9.76

-0.67

+10.43

Martin ratioReturn relative to average drawdown

24.50

-1.39

+25.89

TRT vs. AMPH - Sharpe Ratio Comparison

The current TRT Sharpe Ratio is 3.20, which is higher than the AMPH Sharpe Ratio of -0.57. The chart below compares the historical Sharpe Ratios of TRT and AMPH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


TRTAMPHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.20

-0.57

+3.77

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.40

-0.02

+0.41

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.29

0.03

+0.26

Sharpe Ratio (All Time)

Calculated using the full available price history

0.12

0.15

-0.03

Drawdowns

TRT vs. AMPH - Drawdown Comparison

The maximum TRT drawdown since its inception was -95.03%, which is greater than AMPH's maximum drawdown of -74.05%. Use the drawdown chart below to compare losses from any high point for TRT and AMPH.


Loading charts...

Drawdown Indicators


TRTAMPHDifference

Max Drawdown

Largest peak-to-trough decline

-95.03%

-74.05%

-20.98%

Max Drawdown (1Y)

Largest decline over 1 year

-40.50%

-45.25%

+4.75%

Max Drawdown (3Y)

Largest decline over 3 years

-41.95%

-74.05%

+32.10%

Max Drawdown (5Y)

Largest decline over 5 years

-69.77%

-74.05%

+4.28%

Max Drawdown (10Y)

Largest decline over 10 years

-70.64%

-74.05%

+3.41%

Current Drawdown

Current decline from peak

-40.50%

-72.12%

+31.62%

Average Drawdown

Average peak-to-trough decline

-68.06%

-23.98%

-44.08%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.09%

21.90%

-5.81%

Volatility

TRT vs. AMPH - Volatility Comparison

Trio-Tech International (TRT) has a higher volatility of 66.25% compared to Amphastar Pharmaceuticals, Inc. (AMPH) at 26.71%. This indicates that TRT's price experiences larger fluctuations and is considered to be riskier than AMPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TRTAMPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

66.25%

26.71%

+39.54%

Volatility (6M)

Calculated over the trailing 6-month period

105.38%

45.74%

+59.64%

Volatility (1Y)

Calculated over the trailing 1-year period

123.59%

53.42%

+70.17%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

79.86%

44.99%

+34.87%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

67.66%

42.65%

+25.01%

Dividends

TRT vs. AMPH - Dividend Comparison

Neither TRT nor AMPH has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

TRT vs. AMPH - Financials Comparison

This section allows you to compare key financial metrics between Trio-Tech International and Amphastar Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M202220232024202520260
171.17M
(TRT) Total Revenue
(AMPH) Total Revenue
Values in USD except per share items

Frequently Asked Questions


TRT and AMPH have a correlation of -0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TRT has higher volatility (66.25%) compared to AMPH (26.71%). In terms of maximum drawdown, TRT dropped -95.03% vs AMPH's -74.05%.

TRT currently has the higher Sharpe Ratio (3.20 vs -0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TRT and AMPH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer